Abstract:The remarkable increase of neurodegenerative diseases has become a serious public health problem. Considering the lack of effective treatments to address these diseases and the difficulties in accessing the brain due to the blood–brain barrier, to attain a successful strategy to improve drug delivery to the brain, the administration route becomes a point of interest. In this emergence, the present investigation is designed to develop the chitosan-coated peptide-loaded nano-lipid carrier (CSPepNLC) and characterized by various physico-chemical methods such as laser light scattering for particle size and size distribution, zeta-potential, scanning electron microscope (SEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), loading, and association efficiency and peptide release rate. The stability of CSPepNLC is screened in plasma, erythrocytes, and genotoxicity in pUC18. In addition, we examined the hatching rate, heart rate, survival rate, mortality rate, deformities, and apoptosis and embryo toxicity in Danio rerio model. Initially, NLC-S1, S2, S3, and S4 and nano-lipid carriers are formulated, and NLC-S4 is selected for the CSPepNLC formulation. CSPepNLC exhibited a particle size of 113.33 nm with PDI 0.301 and zeta potential + 28.18 mV. The association, loading efficiency, and release rate of CSPepNLC were observed to be 94.41 ± 0.943%, 11.54 ± 0.572%, and 57% at 30 h. Formulated CSPepNLC was spherical in shape whose size ranges 110–120 nm. Finally, FTIR results confirmed the formation and stability of CSPepNLC. The CSPepNLC exhibited 85% stability at 150 min when incubated with plasma; miniscule hemolysis and absence of hemagglutination are noticed after incubation with erythrocytes. The CSPepNLC revealed the absence of genotoxicity in the pUC18 plasmid DNA nicking assay. The embryo toxicity of CSPepNLC in zebrafish is observed in a time- and dose-dependent manner. Our proposed results concluded that CSPepNLC is observed to be nontoxic at lower concentrations (12.5–100 μg/ml). In specifically, 200 μg/ml of CSPepNLC causes slight zebrafish embryo deformities while screening. Finally, although these results seem promising, further modifications in the CSPepNLC formulation are defensible to enhance the percentage of particles reaching the brain after their administration. This desirable drug carrier system demonstrates advantages such as good biocompatibility, low toxicity, drug release modulation, and the possibility of established mass production. The emergence of nanomaterial research is an important and new prospect to develop unique techniques widely used against several pharmaceutical applications. In this study, the obtained results proved that biogenic nanomaterial are great promising biological activity for a developing sustainable ecosystem.

Nanostructured lipid carriers decorated with polyphosphate coated linear and loop cell-penetrating peptides

Membrane Molecular Interactions and Induced Structures of CPPs

Cell Penetrating Peptide-Based Polyplexes Shelled with Polysaccharide to Improve Stability and Gene Transfection.

Charge-converting nanocarriers: Phosphorylated polysaccharide coatings for overcoming intestinal barriers

An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery

Investigation of enhanced intracellular delivery of nanomaterials modified with novel cell-penetrating zwitterionic peptide-lipid derivatives

Development of Neuropeptide Y and Cell-Penetrating Peptide MAP Adsorbed onto Lipid Nanoparticle Surface

Highlights on Cell-Penetrating Peptides and Polymer-Lipid Hybrid Nanoparticle: Overview and Therapeutic Applications for Targeted Anticancer Therapy

Diversely Substituted Poly( N -Vinyl Amide) Derivatives towards Non-Toxic, Stealth and pH-Responsive Lipid Nanocapsules

Conditional Cell-Penetrating Peptide Exposure as Selective Nanoparticle Uptake Signal

Lipid–Cell-Penetrating-Peptide Conjugates As Effective Delivery Systems

Cell‐Penetrating‐Peptide‐Coated Nanoribbons for Intracellular Nanocarriers

Enhancing the Receptor-Mediated Cell Uptake of PLGA Nanoparticle for Targeted Drug Delivery by Incorporation Chitosan Onto the Particle Surface

Cell-penetrating peptides with nanoparticles hybrid delivery vectors and their uptake pathways

Anionic Calixarenes in Biomembrane Transport of Peptides

Lipid Layer Engineering of Poly(lactide-Co-glycolide) Nanoparticles to Control Their Uptake and Intracellular Co-Localisation.

A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs

Effect of the Lipid Landscape on the Efficacy of Cell-Penetrating Peptides

Cellular internalization pathway and transcellular transport of pegylated polyester nanoparticles in Caco-2 cells

Calcium phosphate increases the encapsulation efficiency of hydrophilic drugs (proteins, nucleic acids) into poly(d,l-lactide-co-glycolide acid) nanoparticles for intracellular delivery

Design, preparation, and in vitro characterizations of chitosan-loaded nanostructured lipid carriers: a promising drug delivery system